INACTIVATED POLIO AND RABIES VACCINES MARKET ANALYSIS

Inactivated Polio And Rabies Vaccines Market, by Vaccine ( Inactivated Polio Vaccines and Inactivated Rabies Vaccines), By Method of Inactivation (Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation, and Others), By Age Group (Pediatrics and Adults), by Distribution Channel (Government and Private) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Jun 2023
Code : CMI3581
Pages :179
Formats :
Excel and PDF
Industry : Biotechnology

Market News

Global Inactivated Polio And Rabies Vaccines Market: Key Developments

In April 2022, Cadila Pharmaceuticals is an Indian multinational pharmaceutical company based in India, launched world’s first three-dose anti-rabies vaccine. Its recombinant nano particle-based rabies G protein vaccine.

In September 2021, Serum Institute of India Pvt. Ltd Pharmaceutical company in India, had start supplying Inactivated Polio Vaccine (IPV) to the Union government for the Universal Immunization Programme. Union health ministry had placed a purchase order with Serum Institute of India for 54 lakh doses of IPV vaccine.

In June 2022, Bharat Biotech ltd. Is a biotechnology company, introduced new variant of INDIRAB is prepared using the strain obtained from Centers for Disease Control and Prevention, USA. A cell culture-derived vaccine, it is produced in Vero Cells, inactivated, and chromatographically purified.